The differences in care models for psilocybin and ketamine are likely driven by sociohistorical factors, such as ketamine's established use as a medical anesthetic versus psilocybin's disappearance and recent re-emergence, rather than pharmacological or neural differences.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (2)

• ketamine concept
• psilocybin concept